199 related articles for article (PubMed ID: 105227)
1. Acute leukemia following prolonged cytotoxic agent therapy.
Casciato DA; Scott JL
Medicine (Baltimore); 1979 Jan; 58(1):32-47. PubMed ID: 105227
[TBL] [Abstract][Full Text] [Related]
2. Cancer and secondary leukemia.
Rosner F
Bull Cancer; 1983; 70(1):55-60. PubMed ID: 6573207
[TBL] [Abstract][Full Text] [Related]
3. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
[TBL] [Abstract][Full Text] [Related]
4. Acute leukemia after alkylating-agent therapy of ovarian cancer.
Reimer RR; Hoover R; Fraumeni JF; Young RC
N Engl J Med; 1977 Jul; 297(4):177-81. PubMed ID: 406560
[TBL] [Abstract][Full Text] [Related]
5. Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases.
Cadman EC; Capizzi RL; Bertino JR
Cancer; 1977 Sep; 40(3):1280-96. PubMed ID: 409479
[TBL] [Abstract][Full Text] [Related]
6. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
van Leeuwen FE; Chorus AM; van den Belt-Dusebout AW; Hagenbeek A; Noyon R; van Kerkhoff EH; Pinedo HM; Somers R
J Clin Oncol; 1994 May; 12(5):1063-73. PubMed ID: 8164031
[TBL] [Abstract][Full Text] [Related]
7. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
Pedersen-Bjergaard J; Ersbøll J; Sørensen HM; Keiding N; Larsen SO; Philip P; Larsen MS; Schultz H; Nissen NI
Ann Intern Med; 1985 Aug; 103(2):195-200. PubMed ID: 4014901
[TBL] [Abstract][Full Text] [Related]
8. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
9. Induced acute non-lymphocytic leukemia following long-term chemotherapy: a study of 20 cases.
Kapadia SB; Krause JR; Ellis LD; Pan SF; Wald N
Cancer; 1980 Mar; 45(6):1315-21. PubMed ID: 6928396
[TBL] [Abstract][Full Text] [Related]
10. Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.
Pedersen-Bjergaard J; Specht L; Larsen SO; Ersbøll J; Struck J; Hansen MM; Hansen HH; Nissen NI
Lancet; 1987 Jul; 2(8550):83-8. PubMed ID: 2885581
[TBL] [Abstract][Full Text] [Related]
11. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
12. Acute myelogenous leukaemia following cytotoxic therapy: five cases and a review.
Smith AG; Prentice AG; Lucie NP; Browning JD; Dagg JH; Rowan RM
Q J Med; 1982; 51(202):227-40. PubMed ID: 6955825
[TBL] [Abstract][Full Text] [Related]
13. Second malignancies and chemotherapeutic agents.
Kyle RA
Prog Clin Biol Res; 1983; 132E():45-54. PubMed ID: 6417671
[No Abstract] [Full Text] [Related]
14. Acute leukemia after treatment for ovarian cancer. Report of four cases and review of the literature.
De Gramont A; Remes P; Krulik M; Smadja N; Drolet Y; Donadio D; Louvet C; Brissaud P; Sirinelli A; Dray C
Oncology; 1986; 43(3):165-72. PubMed ID: 3703462
[TBL] [Abstract][Full Text] [Related]
15. Three cases of secondary leukemia. Clinicopathologic findings.
Nemoto K; Honma K; Ohnishi Y; Abe M; Abe A
Acta Pathol Jpn; 1987 May; 37(5):817-30. PubMed ID: 3477055
[TBL] [Abstract][Full Text] [Related]
16. Second malignancies associated with chemotherapeutic agents.
Kyle RA
Semin Oncol; 1982 Mar; 9(1):131-42. PubMed ID: 6803361
[No Abstract] [Full Text] [Related]
17. Development of acute erythroleukemia in B-cell immunoproliferative disorders after prolonged therapy with alkylating drugs.
Cardamone JM; Kimmerle RI; Marshall EY
Am J Med; 1974 Nov; 57(5):836-42. PubMed ID: 4216270
[No Abstract] [Full Text] [Related]
18. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia following non-Hodgkin's lymphoma: danger of prolonged use of chlorambucil as maintenance therapy.
Dumont J; Thiery JP; Mazabraud A; Natali JC; Trapet P; Vilcoq JR
Nouv Rev Fr Hematol (1978); 1980; 22(4):391-404. PubMed ID: 6942388
[TBL] [Abstract][Full Text] [Related]
20. Development of acute nonlymphocytic leukaemia (ANLL) in myelomatosis.
Drivsholm A; Lisse I; Philip P
Scand J Haematol; 1985 Jul; 35(1):35-7. PubMed ID: 4048861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
